Covid-19 in Brazil: A sad scenario

•The COVID-19 pandemic in Brazil has grown rapidly since February, 25.•The lethality rate for COVID-19 in Brazil is greater than those in other countries of Latin America.•An updated web application has been used by some health managers to guide COVID-19 public policies. The main contribution of thi...

Full description

Saved in:
Bibliographic Details
Published in:Cytokine & growth factor reviews Vol. 58; pp. 51 - 54
Main Authors: Marinho, Pedro Rafael D., Cordeiro, Gauss M., Coelho, Hemílio F.C., Brandão, Simone Cristina S.
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-04-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•The COVID-19 pandemic in Brazil has grown rapidly since February, 25.•The lethality rate for COVID-19 in Brazil is greater than those in other countries of Latin America.•An updated web application has been used by some health managers to guide COVID-19 public policies. The main contribution of this article is to report general statistics about COVID-19 in Brazil, based on analysis of accumulated series of confirmed cases, deaths and lethality rates, in addition to presenting graphs of moving averages for states and municipalities. The data show that the pandemic in Brazil has grown rapidly since February 25th (date of the first reported case). Furthermore, the lethality rate of COVID-19 in Brazil is greater than in many other Latin American countries (Chile, Argentina, Uruguay and Paraguay). However, the number of new confirmed cases in Brazil has little statistical relevance because only a small part of the population has been tested. In relation to Brazilian municipalities, we highlight the 10 states with the highest lethality rates, ranked from highest to lowest. Also, predictions about the increaseor decrease innew cases and deaths for states and capital cities are presented. These results can help managers and researchers to better guide their decisions regarding COVID-19.
ISSN:1359-6101
1879-0305
DOI:10.1016/j.cytogfr.2020.10.010